Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice
In a mouse model of Systemic sclerosis low-dose paclitaxel can suppress an important disease-related pathway, that involves TGFβ and Smad, and lessen fibrosis .
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Public Library of Science
2005
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274282/ |